Trump’s Drug Czar Pick Is A Pharmaceutical Industry Darling
Thomas Marino, U.S. Representative for Pennsylvania’s 10th congressional districts, is interviewed in his office in Washington, D.C. Jan. 2, 2012 (Jake Danna Stevens, The Times-Tribune/AP
President Donald Trump’s reported choice to serve as Director of the Office of National Drug Control Policy has raised alarm concerning conflict of interest, as his top pick has been criticized for protecting and benefiting from the pharmaceutical industry.
